Business
Bausch + Lomb Receives European CE Mark Approval for Preloaded LuxLife® Full Range of Vision Intraocular Lens
VAUGHAN, Ontario, May 07, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of vision intraocular lens (IOL). The preloaded IOL provides patients with natural, continuous vision, from distance to near. Today’s announcement reinforces Bausch + Lomb’s commitment to equip cataract surgeons with choices to fit the right lens to the right patient follo
About this update from Bausch + Lomb Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4152,"height":327,"url":"https://media.zenfs.com/en/business-wire.com/f6870072c49e88f3155aca7b5555bc60"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QD4eYbjexVlM1LZdB1_IjA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTc2O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/f6870072c49e88f3155aca7b5555bc60","width":960,"height":76},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/4IiuQIQFkt1WeLaCY11Ugg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xOTA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/f6870072c49e88f3155aca7b5555bc60","width":1200,"height":95}},"lazy":false},{"type":"text","content":"VAUGHAN, Ontario, May 07, 2025--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for the LuxLife full range of vision intraocular lens (IOL). The preloaded IOL provides patients with natural, continuous vision, from distance to near. Today’s announcement reinforces Bausch + Lomb’s commitment to equip cataract surgeons with choices to fit the right lens to the right patient following the recent launches of enVista® Envy™ full range of vision lenses in the United States and Canada and enVista Aspire™ intermediate-optimized IOLs in Europe.","length":678,"tagName":"p"},{"type":"text","content":""This platform has delivered both quality of vision and patient satisfaction since its introduction," said Luc Bonnefoy, president, Surgical, Bausch + Lomb. "LuxLife is an example of how we plan to build on that success by developing premium options designed to meet the evolving needs of surgeons and patients."","length":332,"tagName":"p"},{"type":"text","content":"In a multicenter, comparative clinical study evaluating the LuxLife IOL versus the monofocal LuxGood® IOL, patients experienced excellent binocular visual outcomes with LuxLife at all distances, near, intermediate and far.1 The LuxLife lens also delivered a high level of patient satisfaction with 95.6% of patients reporting spectacle independence at intermediate distance and 89.5% at near.1","length":393,"tagName":"p"},{"type":"text","content":"With Pure Refractive Optics (PRO) Technology, this non-di...